Risk for Congenital Anomalies in Children Conceived With Medically Assisted Fertility Treatment : A Population-Based Cohort Study.


Journal

Annals of internal medicine
ISSN: 1539-3704
Titre abrégé: Ann Intern Med
Pays: United States
ID NLM: 0372351

Informations de publication

Date de publication:
10 2023
Historique:
medline: 1 11 2023
pubmed: 9 10 2023
entrez: 9 10 2023
Statut: ppublish

Résumé

More than 2 million children are conceived annually using assisted reproductive technologies (ARTs), with a similar number conceived using ovulation induction and intrauterine insemination (OI/IUI). Previous studies suggest that ART-conceived children are at increased risk for congenital anomalies (CAs). However, the role of underlying infertility in this risk remains unclear, and ART clinical and laboratory practices have changed drastically over time, particularly there has been an increase in intracytoplasmic sperm injection (ICSI) and cryopreservation. To investigate the role of underlying infertility and fertility treatment on CA risks in the first 2 years of life. Propensity score-weighted population-based cohort study. New South Wales, Australia. 851 984 infants (828 099 singletons and 23 885 plural children) delivered between 2009 and 2017. Adjusted risk difference (aRD) in CAs of infants conceived through fertility treatment compared with 2 naturally conceived (NC) control groups-those with and without a parental history of infertility (NC-infertile and NC-fertile). The overall incidence of CAs was 459 per 10 000 singleton births and 757 per 10 000 plural births. Compared with NC-fertile singleton control infants ( This study measured the risk for CAs only in those children who were born at or after 20 weeks' gestation. Observational study design precludes causal inference. Many estimates were imprecise. Patients should be counseled on the small increased risk for genitourinary abnormalities after ART, particularly after ICSI, which should be avoided in couples without problems of male infertility. Australian National Health and Medical Research Council.

Sections du résumé

BACKGROUND
More than 2 million children are conceived annually using assisted reproductive technologies (ARTs), with a similar number conceived using ovulation induction and intrauterine insemination (OI/IUI). Previous studies suggest that ART-conceived children are at increased risk for congenital anomalies (CAs). However, the role of underlying infertility in this risk remains unclear, and ART clinical and laboratory practices have changed drastically over time, particularly there has been an increase in intracytoplasmic sperm injection (ICSI) and cryopreservation.
OBJECTIVE
To investigate the role of underlying infertility and fertility treatment on CA risks in the first 2 years of life.
DESIGN
Propensity score-weighted population-based cohort study.
SETTING
New South Wales, Australia.
PARTICIPANTS
851 984 infants (828 099 singletons and 23 885 plural children) delivered between 2009 and 2017.
MEASUREMENTS
Adjusted risk difference (aRD) in CAs of infants conceived through fertility treatment compared with 2 naturally conceived (NC) control groups-those with and without a parental history of infertility (NC-infertile and NC-fertile).
RESULTS
The overall incidence of CAs was 459 per 10 000 singleton births and 757 per 10 000 plural births. Compared with NC-fertile singleton control infants (
LIMITATIONS
This study measured the risk for CAs only in those children who were born at or after 20 weeks' gestation. Observational study design precludes causal inference. Many estimates were imprecise.
CONCLUSION
Patients should be counseled on the small increased risk for genitourinary abnormalities after ART, particularly after ICSI, which should be avoided in couples without problems of male infertility.
PRIMARY FUNDING SOURCE
Australian National Health and Medical Research Council.

Identifiants

pubmed: 37812776
doi: 10.7326/M23-0872
doi:

Types de publication

Observational Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1308-1320

Auteurs

Christos Venetis (C)

National Perinatal Epidemiology and Statistics Unit (NPESU), Centre for Big Data Research in Health, and School of Clinical Medicine, Faculty of Medicine, University of New South Wales, Sydney, Australia, Unit for Human Reproduction, 1 Department of Obstetrics and Gynaecology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece, and Virtus Health, Sydney Australia (C.V.).

Stephanie K Y Choi (SKY)

National Perinatal Epidemiology and Statistics Unit (NPESU), Centre for Big Data Research in Health, and School of Clinical Medicine, Faculty of Medicine, University of New South Wales, Sydney, Australia (S.K.Y.C., X.Z., G.M.C.).

Louisa Jorm (L)

Centre for Big Data Research in Health, Faculty of Medicine, University of New South Wales, Sydney, Australia (L.J.).

Xian Zhang (X)

National Perinatal Epidemiology and Statistics Unit (NPESU), Centre for Big Data Research in Health, and School of Clinical Medicine, Faculty of Medicine, University of New South Wales, Sydney, Australia (S.K.Y.C., X.Z., G.M.C.).

William Ledger (W)

School of Clinical Medicine, Faculty of Medicine, University of New South Wales, Sydney, Australia (W.L., K.L.).

Kei Lui (K)

School of Clinical Medicine, Faculty of Medicine, University of New South Wales, Sydney, Australia (W.L., K.L.).

Alys Havard (A)

National Drug and Alcohol Research Centre and School of Population Health, Faculty of Medicine, University of New South Wales, Sydney, Australia (A.H.).

Michael Chapman (M)

IVFAustralia, and School of Clinical Medicine, Faculty of Medicine, University of New South Wales, Sydney, Australia (M.C.).

Robert J Norman (RJ)

The Robinson Research Institute, The University of Adelaide, Adelaide, South Australia, Australia (R.J.N.).

Georgina M Chambers (GM)

National Perinatal Epidemiology and Statistics Unit (NPESU), Centre for Big Data Research in Health, and School of Clinical Medicine, Faculty of Medicine, University of New South Wales, Sydney, Australia (S.K.Y.C., X.Z., G.M.C.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH